- 5 Ergebnisse
Kleinster Preis: € 171,49, größter Preis: € 235,39, Mittelwert: € 213,85
1
Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - Mark Slevin
Bestellen
bei AbeBooks.de
€ 196,91
Versand: € 0,001
Bestellengesponserter Link
Mark Slevin:

Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - gebunden oder broschiert

2010, ISBN: 9048194946

[EAN: 9789048194940], Neubuch, [PU: Springer Netherlands], GENETIK / HUMANGENETIK; KREBS (KRANKHEIT); TUMOR KREBS; NEURO.; NEUROLOGIE (KRANKHEIT) ONKOLOGIE; ONKOLOGIE - RADIOONKOLOGIE; IM… Mehr…

NEW BOOK. Versandkosten:Versandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
2
Therapeutic Angiogenesis for Vascular Diseases - Mark Slevin
Bestellen
bei lehmanns.de
€ 235,39
Versand: € 0,001
Bestellengesponserter Link

Mark Slevin:

Therapeutic Angiogenesis for Vascular Diseases - gebunden oder broschiert

2010, ISBN: 9789048194940

Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease, Buch, Hardcover, Angiogenesis is the growth of new blood vessels and is a key process which … Mehr…

Versandkosten:sofort lieferbar. (EUR 0.00)
3
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease
Bestellen
bei amazon.co.uk
£ 146,94
(ca. € 171,49)
Versand: € 5,601
Bestellengesponserter Link
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - gebunden oder broschiert

2010

ISBN: 9789048194940

Editor: Slevin, Mark, Springer, Hardcover, Auflage: 2011, 446 Seiten, Publiziert: 2010-10-13T00:00:01Z, Produktgruppe: Book, Hersteller-Nr.: 29750280, 0.92 kg, Books Global Store, Special… Mehr…

Versandkosten:Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 5.60)
4
Therapeutic Angiogenesis for Vascular Diseases Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - Slevin, Mark (Herausgeber)
Bestellen
bei Achtung-Buecher.de
€ 235,39
Versand: € 0,001
Bestellengesponserter Link
Slevin, Mark (Herausgeber):
Therapeutic Angiogenesis for Vascular Diseases Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - gebunden oder broschiert

2010, ISBN: 9048194946

Gebundene Ausgabe Genetik / Humangenetik, Humangenetik, Krebs (Krankheit), Tumor / Krebs, Neuro..., Neurologie / Neuro..., Forschung (medizinisch, psychologisch), Heilkunde, Humanmedizin… Mehr…

Versandkosten:Versandkostenfrei innerhalb der BRD. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
5
Bestellen
bei AbeBooks.de
€ 230,07
Versand: € 1,741
Bestellengesponserter Link
Mark Slevin:
Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - gebunden oder broschiert

2010, ISBN: 9048194946

[EAN: 9789048194940], Neubuch, [PU: Springer], PRINT ON DEMAND Book; New; Fast Shipping from the UK., Books

NEW BOOK. Versandkosten: EUR 1.74 Ria Christie Collections, Uxbridge, United Kingdom [59718070] [Rating: 5 (von 5)]

1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.

Bibliographische Daten des bestpassenden Buches

Details zum Buch
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease

Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the "angiogenic switch", pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.

Detailangaben zum Buch - Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease


EAN (ISBN-13): 9789048194940
ISBN (ISBN-10): 9048194946
Gebundene Ausgabe
Erscheinungsjahr: 2010
Herausgeber: Springer
430 Seiten
Gewicht: 0,924 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 2007-02-10T07:43:03+01:00 (Berlin)
Detailseite zuletzt geändert am 2023-07-07T02:47:54+02:00 (Berlin)
ISBN/EAN: 9048194946

ISBN - alternative Schreibweisen:
90-481-9494-6, 978-90-481-9494-0
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: mark
Titel des Buches: therapeutic angiogenesis for vascular diseases molecular mechanisms and targeted clinical approaches for the treatment angiogenic disease


Daten vom Verlag:

Autor/in: Mark Slevin
Titel: Therapeutic Angiogenesis for Vascular Diseases - Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease
Verlag: Springer; Springer Netherland
430 Seiten
Erscheinungsjahr: 2010-10-13
Dordrecht; NL
Gedruckt / Hergestellt in Niederlande.
Gewicht: 0,916 kg
Sprache: Englisch
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XVI, 430 p.

BB; Cancer Research; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Angiogenesis; Imaging; Therapy; Oncology; Molecular Medicine; Neurosciences; Human Genetics; Cancer Biology; Oncology; Biomedical Research; Neuroscience; Medical Genetics; Medizinische Forschung; Neurowissenschaften; Genetik, Medizin; BC; EA

Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the “angiogenic switch”, pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.

< zum Archiv...